OUR
Recent Articles
Prosecution pathway for pharma & bio patents in india – part 1 The Indian pharmaceutical industry,...
Considering the IP and Legal Implications of Gene Editing Global food security is increasingly challenging...
Korean practice is quite strict, with respect to requirements for claiming small molecules, which are...
Patent protection remains a crucial form of market exclusivity for new pharmaceutical drugs. But with...
What is a “patent cliff?” A “Patent cliff” is the sharp share price or revenue drop immediately after...
Prosecution Pathway for Pharma & Bio Patents in India
Prosecution pathway for pharma & bio patents in india –
azami
December 1, 2021
Looking to Science for Food Security Solutions
Considering the IP and Legal Implications of Gene Editing Global
azami
December 1, 2021
How to Focus on Small Molecules in Written Description and Enablement
Korean practice is quite strict, with respect to requirements for
azami
October 2, 2021
European Supplementary Protection Certificates (SPCs) for pharmaceuticals: A practical guide
Patent protection remains a crucial form of market exclusivity for
azami
October 2, 2021
The Perils of a Patent Cliff and Using Strategic Intellectual Property Portfolio Management to Mitigate Economic Impact of Patent Cliffs
What is a “patent cliff?” A “Patent cliff” is the
azami
October 2, 2021
Canadian Patent Practice: Written Description and Enablement
The Canadian Patent Act and Rules require that the specification correctly
azami
April 2, 2021
Get our insights delivered straight to your inbox.
